// App-Quantinova.ai

1812 : Periprocedural Interruption of Edoxaban in Real World Setting: Results from the Emit AF/VTE Study

Researchers

Presenter

  • Amparo Santamaria

Principal Investigators

  • Paolo Colonna

  • Christian von Heymann

  • Manish Saxena

  • Thomas Vanassche

  • James Jin

  • Robert Wilkins

  • Cathy Chen

  • Martin Unverdorben

Medical Centers

  • University Hospitals of Vinalopo and Torrevieja, Alicante, Spain

  • Polyclinic Hospital of Bari, Bari, Italy

  • Vivantes Klinikum Am Friedrichshain, Berlin, Germany

  • Barts Health NHS Trust, London, United Kingdom

  • Global Biostatistics, Daiichi Sankyo, Basking Ridge, NJ

  • QPS Consulting, LLC, Ashburn, VA

  • Global Medical Affairs, Daiichi Sankyo, Basking Ridge, NJ

Locations

  • Spain

  • Italy

  • Germany

  • United Kingdom

  • Belgium

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Edoxaban

Outcome

  • N/A


Study Design

  • Non Interventional

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A